| 14th Jun 2021 7:00 am |
RNS |
Bexmarilimab granted key US patent |
| 3rd Jun 2021 7:00 am |
RNS |
Bexmarilimab results published in CCR |
| 17th May 2021 7:00 am |
RNS |
Bexmarilimab shows promising anti-tumour activity |
| 14th May 2021 7:00 am |
RNS |
US rights to patent related to Traumakine |
| 10th May 2021 2:30 pm |
RNS |
Holding(s) in Company |
| 29th Apr 2021 12:45 pm |
RNS |
Grant of options |
| 23rd Apr 2021 1:45 pm |
RNS |
Board Change |
| 23rd Apr 2021 1:45 pm |
RNS |
Result of AGM |
| 29th Mar 2021 7:00 am |
RNS |
Appointment of a Broker |
| 25th Mar 2021 7:45 am |
RNS |
Exercise of Options |
| 25th Mar 2021 7:30 am |
RNS |
Notice of Faron Pharmaceuticals Ltd’s AGM |
| 25th Mar 2021 7:15 am |
RNS |
Faron´s Annual Report 2020 published |
| 25th Mar 2021 7:00 am |
RNS |
Financial statement January 1 to December 31 2020 |
| 22nd Mar 2021 7:00 am |
RNS |
Bexmarilimab (Clevegen) development update |
| 11th Mar 2021 7:00 am |
RNS |
Faron to Present at Oppenheimer Conference |
| 2nd Mar 2021 7:00 am |
RNS |
Faron to Present at H.C. Wainwright Conference |
| 25th Feb 2021 7:00 am |
RNS |
Notice of Full-Year Results and Annual Report |
| 17th Feb 2021 4:30 pm |
RNS |
Holding(s) in Company |
| 12th Feb 2021 3:00 pm |
RNS |
Registration of Placing Shares |
| 12th Feb 2021 7:00 am |
RNS |
Results of Placing and Issue Price |
| 11th Feb 2021 4:30 pm |
RNS |
Proposed Issue and Placing of Shares |
| 26th Jan 2021 7:00 am |
RNS |
Update on TRAUMAKINE development |
| 20th Jan 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 20th Jan 2021 2:01 pm |
RNS |
Price Monitoring Extension |
| 20th Jan 2021 7:00 am |
RNS |
Bexmarilimab (Clevegen) development update |
| 18th Jan 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 18th Jan 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 18th Jan 2021 11:06 am |
RNS |
Second Price Monitoring Extn |
| 18th Jan 2021 11:01 am |
RNS |
Price Monitoring Extension |
| 18th Jan 2021 7:00 am |
RNS |
US Department of Defense to support TRAUMAKINE |
| 4th Jan 2021 7:00 am |
RNS |
Faron to Present at H.C. Wainwright |
| 21st Dec 2020 7:00 am |
RNS |
Faron’s financial calendar for 2021 |
| 10th Dec 2020 7:00 am |
RNS |
Presents at ESMO Immuno-Oncology Virtual Congress |
| 23rd Nov 2020 7:30 am |
RNS |
To Participate in Upcoming Investor Conferences |
| 23rd Nov 2020 7:00 am |
RNS |
Bexmarilimab (Clevegen) development update |
| 20th Nov 2020 7:00 am |
RNS |
Issue of Equity |
| 16th Oct 2020 11:35 am |
RNS |
First Results from WHO Solidarity Trial |
| 14th Oct 2020 2:15 pm |
RNS |
Grant of options |
| 30th Sep 2020 9:45 am |
RNS |
Holding(s) in Company |
| 24th Sep 2020 7:15 am |
RNS |
Exercise of options |
